THE EPIVAX THERAPEUTICS TEAM

Management Committee

DAN ADAMS, JD

Chairman, EpiVax Therapeutics

Daniel Adams is the Executive Chairman and Co‐Founder of NextWaveBio, a next‐generation biotechnology enterprise developing safer, more affordable pharmaceuticals. Previously, Dan founded and managed several biotechnology companies including Biogen that achieved a combined value of well in excess of $60 billion.

ANNE (ANNIE) DE GROOT, MD

Co-Founder, CEO & CSO @ EpiVax

Annie is internationally known for her research on the human immune system’s response to vaccines and therapeutics. She is a physician, immunologist, and co-founder and CEO/CSO of the immunoinformatics company, EpiVax.

WILLIAM MARTIN, BA

Co-Founder, COO & CIO @ EpiVax

Bill is the principal architect and developer of the current EpiMatrix System. Over the past 19 years, Mr. Martin has revised and expanded the EpiMatrix toolkit building on the research initially performed in Dr. De Groot's Brown University laboratory.